• Je něco špatně v tomto záznamu ?

Assessment of plasma catecholamines in patients with dysmetabolic iron overload syndrome

HWZ. Hanna, HN. Baz, LFY. Al-Kzayer, HE. El Haddad, F. El-Mougy

. 2022 ; 20 (4) : 141-145. [pub] 20221202

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22034278

BACKGROUND: Dysmetabolic iron overload syndrome (DIOS) is characterized by hyperferritinemia and normal transferrin saturation level with components of metabolic syndrome (MS). Among cases of MS, we determined those with DIOS and their characterizations, then we evaluated the association between plasma catecholamines status and hypertension in DIOS. METHODS: We compared 101 hypertensive patients with 50 healthy participants (control group). Iron (iron, transferrin, and ferritin), insulin, and plasma catecholamine (adrenaline, noradrenaline, and dopamine), profiles were measured for both groups. Homeostasis model assessment of insulin resistance index and transferrin saturation were also calculated. RESULTS: Out of 101 hypertensive patients, 64 were diagnosed with MS, and 6 of the latter met the DIOS diagnostic criteria. Significantly, DIOS patients were older and had lower body mass index (BMI) compared with hypertensive non-DIOS patients with p-values of (0.026), and (0.033), respectively. Adrenaline, noradrenaline, and dopamine levels did not differ significantly between DIOS and non-DIOS patients. CONCLUSIONS: Of the MS patients, 9.3% were diagnosed with DIOS. Accordingly, complete iron profiling should be performed routinely in the cases of MS for early diagnosis of DIOS, to prevent future complications. Further studies are required to test the hypothesis linking older age and lower BMI with the pathogenesis of DIOS.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22034278
003      
CZ-PrNML
005      
20230509134927.0
007      
ta
008      
230207s2022 xr f 000 0|eng||
009      
AR
024    7_
$a 10.32725/jab.2022.016 $2 doi
035    __
$a (PubMed)36708719
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Hanna, Hany William Z. $u Cairo University, Kasr Al Ainy, Faculty of Medicine, Department of Clinical and Chemical Pathology, Cairo, Egypt
245    10
$a Assessment of plasma catecholamines in patients with dysmetabolic iron overload syndrome / $c HWZ. Hanna, HN. Baz, LFY. Al-Kzayer, HE. El Haddad, F. El-Mougy
520    9_
$a BACKGROUND: Dysmetabolic iron overload syndrome (DIOS) is characterized by hyperferritinemia and normal transferrin saturation level with components of metabolic syndrome (MS). Among cases of MS, we determined those with DIOS and their characterizations, then we evaluated the association between plasma catecholamines status and hypertension in DIOS. METHODS: We compared 101 hypertensive patients with 50 healthy participants (control group). Iron (iron, transferrin, and ferritin), insulin, and plasma catecholamine (adrenaline, noradrenaline, and dopamine), profiles were measured for both groups. Homeostasis model assessment of insulin resistance index and transferrin saturation were also calculated. RESULTS: Out of 101 hypertensive patients, 64 were diagnosed with MS, and 6 of the latter met the DIOS diagnostic criteria. Significantly, DIOS patients were older and had lower body mass index (BMI) compared with hypertensive non-DIOS patients with p-values of (0.026), and (0.033), respectively. Adrenaline, noradrenaline, and dopamine levels did not differ significantly between DIOS and non-DIOS patients. CONCLUSIONS: Of the MS patients, 9.3% were diagnosed with DIOS. Accordingly, complete iron profiling should be performed routinely in the cases of MS for early diagnosis of DIOS, to prevent future complications. Further studies are required to test the hypothesis linking older age and lower BMI with the pathogenesis of DIOS.
650    _2
$a lidé $7 D006801
650    12
$a metabolický syndrom $x diagnóza $x komplikace $x metabolismus $7 D024821
650    _2
$a katecholaminy $7 D002395
650    _2
$a dopamin $7 D004298
650    12
$a přetížení železem $x diagnóza $x komplikace $7 D019190
650    _2
$a železo $x metabolismus $7 D007501
650    _2
$a transferin $x metabolismus $7 D014168
650    _2
$a noradrenalin $7 D009638
650    _2
$a adrenalin $7 D004837
655    _2
$a časopisecké články $7 D016428
700    1_
$a Baz, Heba N. $u Cairo University, Kasr Al Ainy, Faculty of Medicine, Department of Clinical and Chemical Pathology, Cairo, Egypt
700    1_
$a Al-Kzayer, Lika'a Fasih Y. $u Shinshu University School of Medicine, Department of Pediatrics, Matsumoto, Nagano, Japan
700    1_
$a El Haddad, Hemmat E. $u Cairo University, Kasr Al Ainy, Faculty of Medicine, Department of Internal Medicine, Cairo, Egypt
700    1_
$a El-Mougy, Fatma $u Cairo University, Kasr Al Ainy, Faculty of Medicine, Department of Clinical and Chemical Pathology, Cairo, Egypt
773    0_
$w MED00012667 $t Journal of applied biomedicine $x 1214-0287 $g Roč. 20, č. 4 (2022), s. 141-145
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36708719 $y Pubmed
910    __
$a ABA008 $b B 2301 $c 1249 $y p $z 0
990    __
$a 20230207 $b ABA008
991    __
$a 20230509134924 $b ABA008
999    __
$a ok $b bmc $g 1896177 $s 1185668
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2022 $b 20 $c 4 $d 141-145 $e 20221202 $i 1214-0287 $m Journal of Applied Biomedicine $n J. Appl. Biomed. (Čes. Budějovice Print) $x MED00012667
LZP    __
$b NLK138 $a Pubmed-20230207

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...